Corporate ActionJul 16, 2026, 06:01 AM
Jaguar Health Registers 5.52M Shares for Resale Following Recent Financing
AI Summary
Jaguar Health, Inc. filed an S-1 registration statement for the resale of up to 5,522,551 shares of common stock by selling stockholders. These shares are linked to recent financing activities, including a $40 million Equity Line of Credit and a $2 million Series P Preferred Stock financing. The company will not receive any proceeds from the resale of these shares. Additionally, the company recently completed the conversion of Series O Preferred Stock into 4,857,211 common shares.
Key Highlights
- Registers up to 5,522,551 common shares for resale by selling stockholders.
- Shares include 4,395,605 Redemption Shares from Series P Preferred Stock.
- Includes 72,000 Commencement Shares from pre-funded warrants.
- Includes 1,054,946 Dividend Shares from Series P Preferred Stock dividends.
- Entered a $40 million Equity Line of Credit with C/M Capital Master Fund, LP.
- Completed $2 million Series P Preferred Stock financing with selling stockholders.
- Converted Series O Preferred Stock into 4,857,211 common shares on June 25, 2026.
- Common stock outstanding to increase from 4.91M to 10.43M shares after offering.
Price Impact
More from JAGX
Corporate ActionAug 3, 4:44 PM
Jaguar Health Seeks Approval for Series Q Exchange, Warrant Repricing
PartnershipJul 14, 4:17 PM
Jaguar Health Subsidiary Signs New Manufacturing Agreement
Corporate ActionJul 1, 4:37 PM
Jaguar Health Completes Series O Preferred Stock Conversion; 4.86M Common Shares Outstanding